A recent study found that participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...

Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Genetic risk scoring improves COPD detection beyond traditional methods, enabling earlier diagnosis and better patient ...

Chronic Obstructive Pulmonary disease (COPD) has been around for almost 205 years and is one of the most prevalent non-infectious diseases in our country. It is the 2nd leading cause of death and ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...